ZGNX stock forecast
Our latest prediction for Zogenix, Inc.'s stock price was made on the Aug. 10, 2018 when the stock price was at 50.15$.
In the short term (2weeks), ZGNX's stock price should outperform the market by 2.68%. During that period the price should oscillate between -8.64% and +12.13%.
In the medium term (3months), ZGNX's stock price should outperform the market by 0.08%. During that period the price should oscillate between -20.91% and +29.03%.Get email alerts
About Zogenix, Inc.
Zogenix, Inc. is a pharmaceutical company. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -3.30$ per share.
The book value per share is 7.81$
Three months stock forecastAug. 10, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|